Novel function of Oncostatin M as a potent tumour-promoting agent in lung. (Q38979862)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Novel function of Oncostatin M as a potent tumour-promoting agent in lung (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Carl D Richards

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Sean Lauber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Steven Wong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Jean-Claude Cutz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Minoru Tanaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Nicole Barra

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Sárka Lhoták

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

English

0 references

publication date

7 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

831-843

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24976180%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

cites work

Cancer statistics, 2009

1 reference

21 January 2018

Inflammation and cancer

1 reference

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

gp130 at the nexus of inflammation, autoimmunity, and cancer

21 January 2018

1 reference

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

21 January 2018

1 reference

Alternative activation of macrophages: mechanism and functions

21 January 2018

1 reference

Tumor-associated neutrophils: friend or foe?

21 January 2018

1 reference

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression

21 January 2018

1 reference

Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion

21 January 2018

1 reference

Gp130 and the interleukin-6 family of cytokines

21 January 2018

1 reference

Therapeutic targeting of the interleukin-6 receptor.

21 January 2018

1 reference

The gp130 receptor cytokine family: regulators of adipocyte development and function.

21 January 2018

1 reference

Oncostatin M, a multifunctional cytokine

21 January 2018

1 reference

Oncostatin M: a pleiotropic cytokine in the central nervous system

21 January 2018

1 reference

Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis

21 January 2018

1 reference

Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.

21 January 2018

1 reference

Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells

21 January 2018

1 reference

Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M

21 January 2018

1 reference

Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines

21 January 2018

1 reference

Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.

21 January 2018

1 reference

Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53.

21 January 2018

1 reference

Oncostatin M is a growth factor for Ewing sarcoma

21 January 2018

1 reference

Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth

21 January 2018

1 reference

Targeted disruption of oncostatin M receptor results in altered hematopoiesis

21 January 2018

1 reference

Adenovirus vector expressing mouse oncostatin M induces acute-phase proteins and TIMP-1 expression in vivo in mice.

21 January 2018

1 reference

Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis

21 January 2018

1 reference

Pulmonary expression of oncostatin M (OSM) promotes inducible BALT formation independently of IL-6, despite a role for IL-6 in OSM-driven pulmonary inflammation

21 January 2018

1 reference

Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer

21 January 2018

1 reference

Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs

21 January 2018

1 reference

Loss of oncostatin M receptor beta in metastatic melanoma cells

21 January 2018

1 reference

Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.

21 January 2018

1 reference

Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells

21 January 2018

1 reference

c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M.

21 January 2018

1 reference

Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy

21 January 2018

1 reference

Inhibition effect of Oncostatin M on metastatic human lung cancer cells 95-D in vitro and on murine melanoma cells B16BL6 in vivo.

21 January 2018

1 reference

Cloning and characterization of a specific receptor for mouse oncostatin M

21 January 2018

1 reference

Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect

21 January 2018

1 reference

K-ras activation generates an inflammatory response in lung tumors

21 January 2018

1 reference

Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.

21 January 2018

1 reference

The influence of macrophages and the tumor microenvironment on natural killer cells.

21 January 2018

1 reference

Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma

21 January 2018

1 reference

Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype

21 January 2018

1 reference